Biomedicines · 9 authors, 7 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This narrative review traces the history of antiepileptic drug development from serendipitous discoveries, through preclinical and clinical advancements, to modern applications of artificial intelligence. It concludes that future drug development should embrace data-driven, translational, and precision medicine approaches.
The article is a comprehensive narrative review of antiepileptic drug (AED) development history. A key focus is the shift towards using artificial intelligence (AI) to integrate data for discovering new AED targets. The authors conclude that future development must address barriers to treatment in low- and middle-income countries and utilize AI to bridge translational and precision medicine for better efficacy and safety.
